Fahim Farzadfard
Gründer bei DXLab, Inc. (Massachusetts)
Profil
Fahim Farzadfard is the founder of DXLab, Inc. (Massachusetts).
He is currently the President & Director at March Therapeutics, Inc.
Aktive Positionen von Fahim Farzadfard
| Unternehmen | Position | Beginn |
|---|---|---|
March Therapeutics, Inc.
 March Therapeutics, Inc. Medical/Nursing ServicesHealth Services Mitolab, Inc. provides healthcare services. The company is headquartered in Allston, MA. | Präsident | - |
DXLab, Inc. (Massachusetts)
 DXLab, Inc. (Massachusetts) Medical SpecialtiesHealth Technology DXLab, Inc. is an American Massachusetts-based company founded by Ho-Jun Suk, Jeong Seuk Kang, and Fahim Farzadfard, with Ho-Jun Suk serving as the CEO since incorporation. The company specializes in providing rapid and accurate point-of-care diagnostic testing for disease detection, particularly for COVID-19. The company's compact POC COVID-19 testing system allows for convenient testing of multiple samples at once, with accessible sample collection and a simple workflow. The system provides up to 8 accurate results in less than 30 minutes, making it a valuable tool for disease detection in areas without high-tech labs. The team at DXLab consists of engineers, physicists, biologists, and chemists working towards providing affordable disease detection where it is needed most. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
March Therapeutics, Inc.
March Therapeutics, Inc. Medical/Nursing ServicesHealth Services Mitolab, Inc. provides healthcare services. The company is headquartered in Allston, MA. | Health Services |
DXLab, Inc. (Massachusetts)
DXLab, Inc. (Massachusetts) Medical SpecialtiesHealth Technology DXLab, Inc. is an American Massachusetts-based company founded by Ho-Jun Suk, Jeong Seuk Kang, and Fahim Farzadfard, with Ho-Jun Suk serving as the CEO since incorporation. The company specializes in providing rapid and accurate point-of-care diagnostic testing for disease detection, particularly for COVID-19. The company's compact POC COVID-19 testing system allows for convenient testing of multiple samples at once, with accessible sample collection and a simple workflow. The system provides up to 8 accurate results in less than 30 minutes, making it a valuable tool for disease detection in areas without high-tech labs. The team at DXLab consists of engineers, physicists, biologists, and chemists working towards providing affordable disease detection where it is needed most. | Health Technology |
